Olfactory neuroblastoma (Esthesioneuroblastoma): Report of six cases treated by a novel combination of endoscopic surgery and radiosurgery

Citation
F. Unger et al., Olfactory neuroblastoma (Esthesioneuroblastoma): Report of six cases treated by a novel combination of endoscopic surgery and radiosurgery, MIN IN NEUR, 44(2), 2001, pp. 79-84
Citations number
22
Categorie Soggetti
Neurology
Journal title
MINIMALLY INVASIVE NEUROSURGERY
ISSN journal
09467211 → ACNP
Volume
44
Issue
2
Year of publication
2001
Pages
79 - 84
Database
ISI
SICI code
0946-7211(200106)44:2<79:ON(ROS>2.0.ZU;2-6
Abstract
Microsurgical techniques have considerably improved the results of surgical treatment for esthesioneuroblastoma (olfactory neuroblastoma). Nevertheles s, these rare tumours of the frontal skull base are still associated with h igh rates of tumour recurrence and mortality, thus remaining a challenge ev en for experienced surgeons. A novel therapeutic approach that combines end oscopic sinus surgery and radiosurgery (gamma knife) is presented here. Six patients (3 males, 3 females) aged between 27 and 75 years (median 38 year s) were treated between August 1993 and July 1999. Following paranasal and nasal endoscopic sinus surgery, marginal irradiation doses ranging from 16 to 34 Gy were applied radiosurgically involving up to 7 isocentres. At pres ent, the median follow-up period is 57 months (range: 9-79 months). Without mortality, tumour control was achieved in all patients. One patient, who h ad to undergo additional craniotomy because of extensive neoplastic infiltr ation, developed postoperative liquorrhea. In another case the clinical cou rse was complicated by a bilateral frontal sinusitis. All patients complain ed of nasal discharge and crusts. However, a preoperative Karnovsky Index r anging from 80 to 100% remained stable in four patients whereas an improvem ent was observed in two patients. Based on the favourable results observed so far, the combination of endoscopic sinus surgery and radiosurgery can be considered as promising new option for the treatment of esthesio-neuroblas toma that merits further investigation.